MindMaze

Accelerating humanity’s ability to recover, learn and adapt through advanced neuroscience, AI and digital therapeutics.

MindMaze is a global leader in brain technology and digital neurotherapeutics, focused on helping people recover, learn, and adapt after neurological injury and disease. Through FDA- and CE-cleared digital therapeutics, virtual reality, and AI-powered motion analytics, MindMaze delivers high-intensity neurorehabilitation for conditions such as stroke, Parkinson’s disease, spinal cord injury, and traumatic brain injury. Our evidence-driven therapy platforms keep patients engaged with interactive, game-like training from clinic to home, giving clinicians powerful tools and patients more chances to improve function every day. Headquartered in Lausanne, Switzerland with a global presence, MindMaze collaborates with leading hospitals, research centers, and industry partners to redefine brain health and recovery for millions of people worldwide. If you are a patient, caregiver, or clinician who wants to explore advanced neurorehabilitation solutions, follow this page and reach out to learn how MindMaze can support your brain health journey.

18/02/2026

What If Brain Performance Became a Standard Vital Sign?

Today, most brain health interventions begin only after a major event—stroke, diagnosis of Parkinson’s, or noticeable cognitive decline. The same technologies that power MindMaze’s neurorehab platform could potentially support proactive brain performance programs for at risk aging, helping people maintain mobility, balance and cognitive function for longer.

Over time, we envision digital neurotechnology and AI driven assessments being explored as part of future care models, turning brain performance into a longitudinal metric rather than an afterthought.

16/02/2026

Why Neurology Needs Real Time Digital Companions to Traditional Drugs

Neurology drugs often launch into complex real world environments where adherence, lifestyle and rehab intensity greatly influence outcomes. MindMaze’s digital neurotherapeutic and assessment platforms can act as real time companions to these treatments, capturing objective functional data, supporting behavioral interventions and making insights available to care teams. This creates an opportunity for pharma to move beyond static trials and prescriptions toward continuous, data rich treatment ecosystems that better reflect how patients live and recover.

13/02/2026

What Adaptive Neurorehab Looks Like in Practice

No two patients with stroke or Parkinson’s progress in exactly the same way, yet many programs still follow fixed schedules and difficulty curves.

MindMaze leverages session level performance data to help adjust task complexity, intensity and feedback over time, supporting more adaptive therapy pathways creating adaptive pathways that respond to each patient’s real world progression.

The ambition is to move from static protocols to dynamic, data driven plans that support the right challenge, at the right moment, in the right setting.

11/02/2026

When Repetition Becomes Medicine: Behavioral Interventions in Neurology

A growing body of research shows that high dose behavioral interventions – such as exercise, task oriented training, and immersive practice—are associated with functional benefits in both neuroprotective and neurorestorative effects in conditions like stroke, Parkinson’s and at risk aging. MindMaze’s neurotherapeutic portfolio is built around this principle. By structuring thousands of targeted, game like movements into measurable digital therapy activities, MindMaze aims to embed evidence based behavioral science into engaging digital experiences that are more sustainable for patients and more trackable for clinicians.

09/02/2026

Turning Neurorehab from a Cost Center into a Value Driver

For payers and health systems, neurology is often a major cost line driven by long stays, readmissions and functional decline. MindMaze programs are designed to deliver intensive, protocolized training while shifting a large portion of activity to supervised self practice, which is designed to help optimize therapist utilization per hour of therapy and support more efficient care pathways. By combining digital neurotherapeutics, remote monitoring and standardized pathways, aim to support more efficient therapy delivery and clearer measurement of value across inpatient, outpatient, and home care settings.

05/02/2026

Why Digital Neurotherapeutics Should Feel Like a Co Pilot for Clinicians

In neurology, therapists are carrying heavier caseloads than ever, while patients need higher doses and greater intensity of rehabilitation. MindMaze’s digital neurotherapeutics are designed to extend the reach of therapists through automated session delivery, rich movement analytics, and remote monitoring dashboards.

These tools are intended to help clinicians manage care more efficiently, stay aligned to treatment protocols, and focus their time where expert judgment matters most. We’re not replacing clinicians, we’re giving them tools that free up capacity and help extend their reach across inpatient, outpatient, and home settings.

03/02/2026

From Hospital to Independent Living: Rethinking the Neurology Recovery Journey

Most neurological care still drops off sharply once a patient leaves the hospital, even though recovery can continue for months or years. MindMaze Therapeutics is designing a continuous recovery journey that connects intensive in clinic training with structured home programs, remote monitoring and timely therapist intervention, so patients do not face the “rehab cliff” alone. Our goal is simple: keep progress going between visits, make every repetition count, and turn rehabilitation into a continuous, data informed process rather than a one off episode of care.

30/01/2026

MindPod: An AI‑Driven Brain Health Platform

1B+ data points per month, 25+ patents, 12 FDA/CE clearances underpinning software‑delivered neurotherapeutics.

MindMaze Therapeutics has invested around USD 350m over the last decade to build a transformative brain health platform. Today, the platform generates roughly 1 billion to 1.2 billion data points per month from more than 35,000 treated patients, over 200,000 training sessions, and 150 active clinics, underpinned by 25+ patents and 12 regulatory clearances/listings including CE marks and FDA listings.

28/01/2026

MindMotion Go: From Stroke to Parkinson’s: Real Recovery, At Scale

35,000+ patients treated across 150 clinics in 10 countries, supported by robust clinical and real‑world evidence.

High‑dose, high‑intensity rehab should not be a luxury. MindMaze programs have treated more than 35,000 patients across 150 clinics in 10 countries, delivering full‑body, movement-based behavioral therapies for conditions like stroke and Parkinson’s disease. Clinical and real‑world studies show meaningful gains in upper limb function, gait, balance, fall risk and cognition, while reducing costs for providers and payers.

26/01/2026

MindMaze Therapeutics: Shaping the Future of Precision Neurology

AI Powered Neurotherapeutics to Improve the Lives of People with Brain Disorders.

Neurological disorders are now the leading cause of disability worldwide, yet most patients still can’t access intensive, evidence-based rehabilitation at scale.

MindMaze Therapeutics is building an AI Powered precision neurology platform to change that, combining digital neurotherapeutics, assessment tools and pharmacological treatments to improve the lives of people with brain disorders.

From Stroke and Parkinson’s to at‑risk aging, our goal is simple: enable every patient to learn, recover and adapt faster throughout their journey.

23/01/2026

Neurological care breaks down at transitions hospital discharge, outpatient rehab, home follow up. MindMaze is designed to close these gaps by supporting patients continuously from acute care through long term recovery and monitoring.

22/01/2026

Neurological rehabilitation faces a workforce crisis rising patient demand, limited therapist time, and increasing burnout. MindMaze tools are designed to help clinicians extend their reach, monitor more patients, and deliver higher therapy dose without increasing workload.

Adresse

Chemin De Roseneck 5
Lausanne
1006

Telefon

+41 21 552 08 01

Webseite

http://www.MindMazeTx.com/, https://linktr.ee/MindMazeTx

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von MindMaze erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Verknüpfungen

Wollen Sie Ihr Praxis zum Top-Klinik in Lausanne machen?